Our approach to innovation
We are the first MSK charity to actively support start-ups and entrepreneurs.
Our approach to innovation follows in the footsteps of our founder, Ronald Furlong, who combined a highly successful career as an orthopaedic surgeon with an equally successful career as an entrepreneur.
We support entrepreneurially-minded Early Career Researchers who have successfully completed their research projects within MSK health, or who are working on technologies with a potential application to MSK health. We provide them with funding, education, mentoring and networking support to accelerate the translation of their research ideas into new products or services.
Our Ronald Furlong Fund supports the development of innovative and commercially viable ideas from UK start-ups. Learn more.
We created the annual MSK Innovation Accelerator programme, hosted by MedTech SuperConnector at Imperial. The programme is designed to accelerate the development of musculoskeletal innovation and thereby create and scale early-stage MSK ventures across the UK. Learn more.
We work with partners to accelerate the translation of research ideas into new products or services.
We have investments in a growing number of early stage companies pioneering breakthrough MSK technologies.
Deploys state-of-the-art AI and biomechanical modelling to help clinicians design better fitting prosthetic sockets.
Pioneering use of a nanoclay in injectable gel form that can carry biologic drugs capable of augmenting bone tissue regeneration.
Amotio delivers a personalised approach for the safe and effective removal of orthopaedic bone cement during surgery
